“These results represent a significant milestone for PALI-2108,” said JD Finley, Chief Executive Officer of Palisade Bio. “The early clinical activity, targeted delivery, dose flexibility, the ...

Abivax’s ulcerative colitis drug meets primary goals in Phase 3 trials; shares jump 400% Stock Markets Published 07/23/2025, 07:21 AM 0 ...

Topline data were announced from two phase 3 trials evaluating obefazimod in adults with moderately to severely active ulcerative colitis (UC).

In other recent news, Abivax has completed enrollment for its two Phase 3 induction trials for the drug obefazimod, aimed at treating ulcerative colitis. This development is a crucial step in the drug ...

It’s important to know the difference between colitis and ulcerative colitis because treatment for these conditions can differ.

It’s important to know the difference between colitis and ulcerative colitis because treatment for these conditions can differ.